Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/26/2003EP1364032A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364030A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/26/2003EP1364029A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture
11/26/2003EP1364028A2 Regulation of human carboxypeptidase a
11/26/2003EP1364027A2 Zinc finger binding domains for nucleotide sequence ann
11/26/2003EP1364026A2 Human g protein-coupled receptor
11/26/2003EP1364025A1 A novel gene bn01 mapping to chromosome 16q24.3
11/26/2003EP1364024A2 Endogenous and non-endogenous versions of human g protein-coupled receptors
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364022A2 Human leucine-rich repeat containing protein, hlrrbm1, expressed predominately in bone marrow
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364020A2 Position dependent recognition of gnn nucleotide triplets by zinc fingers
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364016A2 Secreted proteins and their uses
11/26/2003EP1364015A2 Molecules for diagnostics and therapeutics
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364013A1 G protein-coupled receptor
11/26/2003EP1364012A2 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
11/26/2003EP1364011A2 Modified thrombopoietin with reduced immunogenicity
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1364009A2 Regulatable, catalytically active nucleic acids
11/26/2003EP1364008A2 Methods for enhancing targeted gene alteration using oligonucleotides
11/26/2003EP1364007A1 Circular extra-chromosomal dna elements
11/26/2003EP1364005A2 A method for evolving a cell having desired phenotype and envolved cells
11/26/2003EP1364004A2 Administration of nucleic acid sequence to female animal
11/26/2003EP1364002A2 Process for the preparation of neutrophil inhibitory factor
11/26/2003EP1363998A1 Novel human poly(a)polymerase gamma (pap gamma)
11/26/2003EP1363997A1 Concentration and lysis of adenovirus-infected cells in a single unit operation
11/26/2003EP1363994A2 Thymic epithelial progenitor cells and uses thereof
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363961A2 End group activated polymers with oligonucleotide ligands
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363947A2 The guinea pig proteinase-activated receptor 4 and its activating peptide
11/26/2003EP1363946A2 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363941A2 Histidine phosphatase interacting protein of 120 kd
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363936A1 Juvenile hormone esterase
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP1363931A2 Methods to generate and identify monoclonal antibodies to a large number of human antigens
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363924A1 Avilamycin derivatives
11/26/2003EP1363714A1 A microchip electrospray device and column with affinity adsorbents and use of the same
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363676A2 Method of enhancing delivery of a therapeutic nucleic acid
11/26/2003EP1363675A2 Compositions useful in gene therapy
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/26/2003EP1363660A2 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
11/26/2003EP1363654A2 Fab i and inhibition of apicomplexan parasites
11/26/2003EP1363653A2 Methods and compositions for enhancing angiogenesis
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363601A2 Amphoteric liposomes and the use thereof
11/26/2003EP1363529A2 Rare event detection system
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP1363487A2 Fungal resistant transgenic plants
11/26/2003EP1107723B1 A carotenoid composition containing phytoene and phytofluene
11/26/2003EP1038031B1 Mass spectrometric methods for sequencing nucleic acids
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP0953056B1 Nucleic acid sequencing with solid phase capturable terminators
11/26/2003EP0871492B1 Mesothelium antigen and methods and kits for targeting it
11/26/2003EP0859627B1 Mimicking peptides in cancer therapy
11/26/2003EP0822861B1 Remotely programmable matrices with memories and uses thereof
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0647280B1 Over-expression of single-stranded dna molecules
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458976A Permeases 2,5-DKG
11/26/2003CN1458975A Marker for detecting plant genome polymorphism with use of transposable element and method of constructing same
11/26/2003CN1458973A Pre-adipose cell lines
11/26/2003CN1458282A Preparing method for producing high level immunity induced by nucleic molecule and using method
11/26/2003CN1458280A Two artificial synthetic PRRS virus multiple opitope tandem pucleotide sequences and their use
11/26/2003CN1458279A Method for preparing small interference RNA molecule by using coli bacillus fermentation
11/26/2003CN1458277A New multifunctional coli bacillus nonfusion protein expressing carrier and its ase
11/26/2003CN1458276A Hydantoin enzyme series and encoded gene and production bacteria thereof
11/26/2003CN1458274A Alkali cellulose enzyme variznt
11/26/2003CN1458272A Green trichodermin with heliphobous gene transformed and its preparing method and use
11/26/2003CN1458170A New human protein with cancer inhibiting function and its encoding sequence
11/26/2003CN1458169A New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence
11/26/2003CN1458168A Recombined pig influenza virus NP antigen, its preparing method and use in diagnosis
11/26/2003CN1458166A Rondom polypeptide library constructing method
11/26/2003CN1458161A Process for producing human insulin using transgenic tomato
11/26/2003CN1458160A Gene recombination tumour blood vessel death factor PFK and its derivative fusion protein
11/26/2003CN1457634A Mouse model of hipatitis B virus gene positioning integration to result in liver cell callcer
11/26/2003CN1128884C Methods and compositions for efficient nucleic acid sequencing
11/26/2003CN1128882C Fermentation method for prepn. of D-pantothenic acid using strain of enterobacteriaceac
11/26/2003CN1128881C Method for improving quality of gramineous crop
11/26/2003CN1128880C Blue alga transgenic expression system and method for expressing thyrnosin alpha 1
11/26/2003CN1128879C Ultrathermostable protease genes
1 ... 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 ... 4023